HIMS Stock On A 3-Day Slide: CFO Cashes Out $229K In Shares Ahead Of FDA Peptide Meeting

HIMS stock declined for three consecutive days.

CFO cashed out $229K in shares during the slide.

The next catalyst is FDA's July 23-24 advisory committee meeting on peptides for section 503A Bulks List.